Richard Walovitch
Keine laufenden Positionen mehr
Profil
Richard Walovitch was Senior Vice President-Clinical Research of Acusphere, Inc. from 2005 to January 2009 and Vice President-Clinical Research from 1997 to January 2009.
Prior to joining Acusphere, he was Vice President-Pre clinical and Clinical Research at Epix Medical, Inc. from 1993 to 1997 and the International Project Clinician at DuPont Merck Pharmaceutical Company from 1988 to 1993.
Dr. Walovitch received a BS in Biology and a PhD in Pharmacology from the University of Illinois.
Ehemalige bekannte Positionen von Richard Walovitch
| Unternehmen | Position | Ende |
|---|---|---|
| ACUSPHERE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.01.2009 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
Ausbildung von Richard Walovitch
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACUSPHERE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
